AHA Scientific Sessions 2025 Abstract
Single dose of a novel CRISPR-CasX editor potently reduces triglycerides in preclinical models and efficiently edits APOC3 in non-human primates
Experiments in animalsInterventions
Papers by Myles Hochman
1 result